Lataa...
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence
With the lack of effective therapy, chemoprevention and vaccination, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Interestingly, montelukast, a drug usually used in asthma, may be proposed as a potential adjuvant therapy in COVID-19. The aim of the pres...
Tallennettuna:
| Julkaisussa: | Front Pharmacol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7500361/ https://ncbi.nlm.nih.gov/pubmed/33013375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01344 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|